Goldman Sachs’s Nutraceutical International Co NUTR Stock Holding History

Goldman Sachs’s Portfolio NUTR Stock Details NUTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,537	Closed	-$314K	–	7087
2017 Q2	$314K	Sell	7,537 -5,706	-43%	-$204K	﹤0.01%	5470
2017 Q1	$413K	Buy	13,243 +5,222	+65%	+$177K	﹤0.01%	5199
2016 Q4	$280K	Sell	8,021 -28,730	-78%	-$910K	﹤0.01%	5540
2016 Q3	$1.15M	Buy	+36,751	New	+$946K	﹤0.01%	4285
2016 Q1	–	Sell	-13,146	Closed	-$339K	–	7501
2015 Q4	$339K	Buy	+13,146	New	+$323K	﹤0.01%	5256
2014 Q3	–	Sell	-14,879	Closed	-$355K	–	7387
2014 Q2	$355K	Buy	14,879 +1,382	+10%	+$33.9K	﹤0.01%	5635
2014 Q1	$351K	Sell	13,497 -2,235	-14%	-$58K	﹤0.01%	5600
2013 Q4	$421K	Buy	15,732 +782	+5%	+$19.4K	﹤0.01%	5429
2013 Q3	$355K	Buy	+14,950	New	+$340K	﹤0.01%	5443

Goldman Sachs's NUTR Position: Q3 2017 in Review

Goldman Sachs sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 7,537 shares — an estimated $314K sold.

Goldman Sachs first reported a position in NUTR in Q3 2013 and held it in 9 quarters. The position peaked at $1.15M in Q3 2016. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

Goldman Sachs reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
Goldman Sachs sold 7,537 Nutraceutical International Co shares in Q3 2017, an estimated $314K.
Goldman Sachs first reported a position in Nutraceutical International Co in Q3 2013 and held it in 9 quarters.
Goldman Sachs's Nutraceutical International Co position peaked at $1.15M in Q3 2016.
0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on Goldman Sachs's 13F filing for Q3 2017, filed 14 Nov 2017.